A Comparative Study Of Role Of Ritodrine Versus Magnesium Sulphate In Preterm Labour

Jagrati Kiran Naagar, Jyoti Bindal

Abstract


Introduction : Preterm delivery which accounts for over 75% of all cases of perinatal mortality and morbidity is the most important obstetric problem of world today.The present study was conducted in the department of obstetrics and gynecology at Kamla Raja Hospital Gwalior. This study is an attempt to study the efficacy of two most commonly used tocolytic agents ritodrine versus magnesium sulphate in controlling preterm labour Methods: The material for the present study comprised of 100 patients who were in preterm labour out of which 50 were given Ritodrine infusion and 50 were given magnesium sulphate.Both the groups were compared for tocolytic efficacy and effect of preterm labour on neonatal .mortality and morbidity. Result: In the present study  >2 days were gained in 28%in Ritodrine group and 26% in magnesium sulphate group.3-6 days gained in 42% cases in Ritodrine group and 46% in magnesium sulphate group.It was observed that maimum time gained in both the groups in majority of cases was up to 6 days. Conclusion: The primary tocolytic agent chosen should be efficient with minimum side effects to mother and fetus. Ritodrine group and magnesium sulphate appears to fulfill  these requirements. Magnesium sulphate is found to be comparable to Ritodrine in terms of efficacy and safety. Magnesium sulphate appears cheaper as compare to Ritodrine.

Full Text:

PDF HTML

References


Fuchs F . Prevention of prematurity. American Journal of Obstetrics and Gynaecology 1976;126(7):809-820.

Janet tucker and William McGuire. Epidemiology of preterm birth. BMJ. 2004; sep 18;329(7467):675-678.

Stacy beck, Daniel wojdyla, paul FA van look. The worldwide incidence of preterm birth: a systemic review of maternal mortality and morbidity. Bull WHO. 2010 Jan;88(1):31-38. doi: 10.2471/BLT.08.062554

Creasy RK and Merkatz IR . Prevention of preterm birth: clinical opinion. Journal of Obstetrics and Gynaecology .1990;76 2S.

Ryan w loftin, mounira habli, Emily a DeFranco. Late preterm birth. Rev Obstet Gynecol. 2010 winter;3(1):10-19.

Cotton DB, Strassner HT, Hill LM et al comparision between Magnesium sulphate terbutaline and placebo. For inhibition of preterm labour. A Randomized study. J Reprod Med. 1984 Feb;29(2):92-7.

. Gray SE Rodis JF Lettieri L, Egan JF,VintzileosA. effect of iv Magnesium sulphate on Biophysical profile of the healthy preterm fetus. Am J Obstet. & Gynecol. 1994 April 170(4), 1131-5.

Hollander D I Nagey Pupkin M J Magnesium sulphate and Ritodrone Hydrochloride a randomized comparision Am J Obstet Gynecol. 1987 Mar;156(3):631-7.

Nelson and Grether protective effect of magnesium against cerebral palsy in very low birth weight infants .Paediatrics1995feb;95(2):263-9.

Doyle LW, Crowther CA, Middleton S,Marret S,Rouse D . Magnesuim sulphate for women at risk of preterm birth for neuroprotection of the fetus. Cochrane Database of Systematic Reviews2009.jan21;( 1) CD 004661.

Larmon JE, Ross BS and May WL,DickersonG A,FisherRG,MorrisonJC. Oral nicardipine versus intravenous magnesium sulphate for the treatment of preterm labour. American Journal of Obstet and Gynaecol 2009.181 (6);1432-1437.

Amita Mahajan and Parveen Marwah Arrest of preterm labour : A Comparative study between magnesium sulphate and isoxsuprime International Journal of Basic and Applied Medical Sciences ISSN: 2277-2103 (Online) 2014 Vol. 4 (3) September-December, pp. 19-25.


Refbacks

  • There are currently no refbacks.